Welcome to LookChem.com Sign In|Join Free
  • or
diphenyl 1-(N-(benzyloxycarbonyl)amino)-1-(4-cyanophenyl)propanephosphonate is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

934622-24-9

Post Buying Request

934622-24-9 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

934622-24-9 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 934622-24-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,3,4,6,2 and 2 respectively; the second part has 2 digits, 2 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 934622-24:
(8*9)+(7*3)+(6*4)+(5*6)+(4*2)+(3*2)+(2*2)+(1*4)=169
169 % 10 = 9
So 934622-24-9 is a valid CAS Registry Number.

934622-24-9Downstream Products

934622-24-9Relevant academic research and scientific papers

Novel Urokinase Inhibitors

-

Page/Page column 31, (2009/01/24)

The present invention relates to novel compounds with inhibitory activity towards urokinase plasminogen activator (uPA); to methods for preparation of said uPA inhibitor compounds; to pharmaceutical compositions comprising said uPA inhibitor compounds; to

Small, potent, and selective diaryl phosphonate inhibitors for urokinase-type plasminogen activator with in vivo antimetastatic properties

Joossens, Jurgen,Ali, Omar M.,El-Sayed, Ibrahim,Surpateanu, Georgiana,Der Van Veken, Pieter,Lambeir, Anne-Marie,Setyono-Han, Buddy,Foekens, John A.,Schneider, Anneliese,Schmalix, Wolfgang,Haemers, Achtel,Augustyns, Koen

, p. 6638 - 6646 (2008/09/17)

A set of small nonpeptidic diaryl phosphonate inhibitors was prepared. Some of these inhibitors show potent and highly selective irreversible uPA inhibition. The biochemical and modeling data prove that the combination of a benzylguanidine moiety with a d

NOVEL UROKINASE INHIBITORS

-

Page/Page column 68-70; 75, (2010/11/27)

The present invention relates to novel compounds with inhibitory activity towards urokinase plasminogen activator (uPA); to methods for preparation of said uPA inhibitor compounds; to pharmaceutical compositions comprising said uPA inhibitor compounds; to

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 934622-24-9